Buy Hutrope Line Pen 30IU 3ML Online Hubio Pharm

Hutrope Line-Pen 30IU is a prescription medication used for the treatment of growth hormone deficiency in children and adults. It contains recombinant human growth hormone (rHGH) and is administered subcutaneously using a medical pen device.

Composition:
Each Hutrope Line-Pen 30IU contains 30 international units (IU) of recombinant human growth hormone, plus excipients such as Glycine, Mannitol, and Sodium Phosphate.

Uses:
Hutrope Line-Pen 30IU is used to treat patients suffering from growth hormone deficiency. This includes children with growth hormone deficiency due to various medical conditions such as Turner syndrome, Prader-Willi syndrome, renal failure, etc. It is also used in adults with growth hormone deficiency, which can cause physical and psychological symptoms such as decreased muscle mass, increased body fat, fatigue, and depression.

HOW TO USE:
Hutrope Line-Pen 30IU is administered subcutaneously using a medical pen device. The injection should be given into the thigh, buttocks, or abdomen. The patient should rotate injection sites to avoid skin irritation and bruising. The doctor or healthcare professional should provide proper instructions on how to use the device and administer the medication.

Dosage:
The dosage of Hutrope Line-Pen 30IU depends on the individual’s age, weight, and medical condition. The usual starting dose for children is 0.025 to 0.035 mg/kg per day, while the maintenance dose is 0.045 to 0.050 mg/kg per day. Adult dosage ranges from 0.15 to 0.3 mg/day, depending on the severity of growth hormone deficiency. The doctor will determine the appropriate dose for each patient.

Storage Conditions:
Hutrope Line-Pen 30IU should be stored in the refrigerator at 2°C to 8°C. Do not freeze the medication. The device can be kept at room temperature for up to 1 month, but it should be used within 28 days after removing it from the refrigerator. The unused medication should be disposed of properly.

Mechanism of action:
Hutrope Line-Pen 30IU contains a synthetic form of human growth hormone that can stimulate bone and tissue growth, promote muscle mass, and reduce body fat. It acts by binding to specific receptors in the liver and stimulate the production of insulin-like growth factor-1 (IGF-1), which plays an essential role in bone growth, cell proliferation, and differentiation.

Precautions:
Patients should have regular appointments with their healthcare provider to monitor their response to the medication and adverse reactions. Hutrope Line-Pen 30IU should not be given to patients with active malignancy or with a history of hypersensitivity to any of the ingredients in the medication.

Contraindications:
Hutrope Line-Pen 30IU is contraindicated in patients with active malignancy or other severe illnesses. It should not be used in patients with a hypersensitivity to any of the ingredients.

Interactions:
Hutrope Line-Pen 30IU may interact with other medications, including corticosteroids, estrogens, and thyroid hormones. Patients should inform their healthcare provider about any medications they are taking.

Overdose:
In case of an overdose, patients may experience symptoms such as headache, nausea, vomiting, and edema. Patients should seek medical attention immediately.

Side effects:
Common side effects of Hutrope Line-Pen 30IU include injection site reactions, such as pain, swelling, and redness. Other side effects may include headaches, joint pain, and muscle pain. Rarely, patients may develop allergic reactions, such as rash or hives, breathing difficulties, or swelling of the face, lips, tongue or throat. If any side effects occur, patients should contact their doctor or healthcare provider.